Peraso Inc. Faces Delisting or Listing Transfer

Ticker: PRSO · Form: 8-K · Filed: Sep 5, 2025 · CIK: 890394

Peraso Inc. 8-K Filing Summary
FieldDetail
CompanyPeraso Inc. (PRSO)
Form Type8-K
Filed DateSep 5, 2025
Risk Levelhigh
Pages2
Reading Time3 min
Key Dollar Amounts$0.001, $1
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-transfer, compliance

TL;DR

Peraso's stock might be delisted or moved to another exchange.

AI Summary

Peraso Inc. filed an 8-K on September 5, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing. The filing indicates a significant event related to the company's stock exchange status.

Why It Matters

This filing signals potential changes in where Peraso Inc.'s stock is traded, which could impact liquidity and investor confidence.

Risk Assessment

Risk Level: high — Delisting or forced listing transfers often indicate severe financial distress or non-compliance with exchange rules, posing significant risk to investors.

Key Players & Entities

  • Peraso Inc. (company) — Registrant
  • September 5, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • 2033 Gateway Pl. Suite 500 San Jose , CA 95110 (address) — Principal executive offices
  • MoSys, Inc. (company) — Former Company Name
  • MONOLITHIC SYSTEM TECHNOLOGY INC (company) — Former Company Name

FAQ

What specific listing rule or standard has Peraso Inc. failed to satisfy?

The filing does not specify the exact rule or standard that Peraso Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

What is the reason for the potential transfer of listing?

The filing states 'Transfer of Listing' as an item of disclosure, but does not provide the specific reasons or the destination exchange for this potential transfer.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on September 5, 2025.

Has Peraso Inc. previously changed its name?

Yes, Peraso Inc. was formerly known as MoSys, Inc. (name change effective May 30, 2006) and prior to that, MONOLITHIC SYSTEM TECHNOLOGY INC (name change effective June 13, 1996).

What is the principal business address of Peraso Inc.?

The principal executive offices of Peraso Inc. are located at 2033 Gateway Pl. Suite 500, San Jose, CA 95110.

Filing Stats: 691 words · 3 min read · ~2 pages · Grade level 13.4 · Accepted 2025-09-05 17:02:29

Key Financial Figures

  • $0.001 — ch registered Common Stock, par value $0.001 per share PRSO The Nasdaq Stock Mar
  • $1 — ment to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listi

Filing Documents

01 Notice of Delisting or Failure to

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 5, 2025, Peraso Inc. (the "Company") received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, based upon the closing bid price of the Company's common stock ("Common Stock") for the 30 consecutive business days ending on September 4, 2025, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until March 4, 2026, in which to regain compliance. In order to regain compliance with the minimum bid price requirement, the closing bid price of the Company's Common Stock must be at least $1 per share for a minimum of ten consecutive business days during this 180-day period. In the event the Company does not regain compliance within this 180-day period, the Company may be eligible to seek an additional compliance period of 180 calendar days provided it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and further provides written notice to Nasdaq of its intent to cure the deficiency during this second compliance period by effecting a reverse stock split, if necessary. However, if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice to the Company that its Common Stock will be subject to delisting. The above mentioned letter does not result in the immediate delisting of the Company's Common Stock from the Nasdaq Capital Market. The Company is monitoring the closing bid price of its Common Stock and considering its available options in the

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.